Novo Nordisk (NYSE: NVO) announced Thursday it will initiate Phase 3 trials for its experimental weight-loss drug amycretin in both injection and oral forms during the first quarter of 2026. The ...

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

Discover the revolutionary blood test that predicts your exact lifespan and healthspan. Learn how one drop of blood reveals ...

Knowable Magazine shares how studies show psychological strain can accelerate tumors and asks if beta blockers slow them down.

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

Have you ever wondered how people survive the blistering, almost surreal heat of the world’s deserts? Picture yourself ...

In a study published in Cell Research, a research team has, for the first time, resolved the high-resolution in situ ...

A research team led by Prof. Cao Xiaofeng from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences has uncovered a key translational regulatory mechanism ...

Poster Title: ARV-393, a PROteolysis TArgeting Chimera (PROTAC) BCL6 Degrader, is Efficacious in Preclinical Models of ...

How New Terra Pro CBD Gummies utilize advanced extraction methods to deliver consistent, potent pain relief benefits in every serving.The science behind CBD’s interaction with your body’s ...

Williams, W. R. (2025) Nucleotide Relative Molecular Similarity within Anti-Psychotic Drug Structures. Journal of Biosciences and Medicines, 13, 106-117. doi: 10.4236/jbm.2025.136010 .

PRINCETON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced new preclinical data on the use of Purified Cortrophin Gel (repository ...